Siren, L.L.C. has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2 Trillion distributed in 112 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $141B, Bei Gene, Ltd. with a value of $126B, Scholar Rock Holding Corp with a value of $90.2B, Bicara Therapeutics Inc with a value of $78.3B, and Argenx Se with a value of $77.9B.
Examining the 13F form we can see an increase of $2T in the current position value.
Siren, L.L.C. is based out at New York, NY
Below you can find more details about Siren, L.L.C. portfolio as well as his latest detailed transactions.